You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Histone Deacetylase (HDAC)

Showing 1 - 25 of 523
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)

Completed
Has Results
  • Melanoma
  • Skin Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 18, 2023

Peripheral T-cell Lymphoma Trial in Shanghai (PD-1 antibody+ HDAC inhibitor)

Recruiting
  • Peripheral T-cell Lymphoma
  • PD-1 antibody+ HDAC inhibitor
  • Shanghai, Shanghai, China
    Dongmei Ji
Dec 3, 2021

Hodgkin's Lymphoma Trial in Milan (histone deacetylase inhibitor (ITF2357))

Terminated
  • Hodgkin's Lymphoma
  • histone deacetylase inhibitor (ITF2357)
  • Milan, Italy
    Istituto Nazionale per lo studio e la cura dei Tumori
Jan 18, 2022

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +20 more
  • Scottsdale, Arizona
  • +1 more
May 6, 2022

Relapsed or Refractory Multiple Myeloma Trial (Vorinostat, Bortezomib, Dexamethasone)

Completed
Has Results
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Mar 5, 2021

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Buffalo, New York
  • +1 more
Aug 11, 2022

Lymphoma, Follicular Trial in China (Abexinostat)

Recruiting
  • Lymphoma, Follicular
  • Beijing, China
  • +25 more
Mar 3, 2022

Heart Failure With Normal Ejection Fraction, Left Ventricular Hypertrophy, Aortic Valve Stenosis Trial in Boston

Recruiting
  • Heart Failure With Normal Ejection Fraction
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 1, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Active, not recruiting
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Los Angeles, California
  • +3 more
Nov 16, 2022

Smoldering Multiple Myeloma Trial in Boston, Durham, Cleveland (Hiltonol, Citarinostat, Lenalidomide)

Recruiting
  • Smoldering Multiple Myeloma
  • Boston, Massachusetts
  • +4 more
Feb 22, 2021

Clinical Relevance of DNMT and HDAC Gene SNP on Response to

Completed
  • Myelodysplastic Syndrome
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Aug 11, 2020

    Chronic Lymphocytic Leukemia Trial in Perugia (ITF2357)

    Terminated
    • Chronic Lymphocytic Leukemia
    • Perugia, Italy
      Department of Internal Medicine and Public Health, University of
    Jan 18, 2022

    Hodgkin's Lymphoma Trial in Milano (ITF2357)

    Completed
    Has Results
    • Hodgkin's Lymphoma
    • Milano, Italy
      Istituto Nazionale per la Cura e lo Studio dei Tumori
    Apr 20, 2021

    Sarcoma Trial in Guangzhou (chidamide and toripalimab)

    Recruiting
    • Sarcoma
    • chidamide and toripalimab
    • Guangzhou, Guangdong, China
      Sun Yat-Sen Univerisity
    Sep 4, 2022

    Ototoxicity, Drug-Induced Trial in Cincinnati (Sodium Thiosulfate)

    Recruiting
    • Ototoxicity, Drug-Induced
    • Sodium Thiosulfate
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Mar 6, 2023

    Histone Deacetylase (HDAC) Activity Trial in Corvallis (BSE , Garlic oil, BSE)

    Terminated
    Has Results
    • Histone Deacetylase (HDAC) Activity
    • BSE placebo
    • +3 more
    • Corvallis, Oregon
      Oregon State University
    Apr 8, 2019

    Multiple Myeloma Trial in United States (ACY-1215, lenalidomide, Dexamethasone)

    Completed
    • Multiple Myeloma
    • Boston, Massachusetts
    • +4 more
    Feb 7, 2022

    Renal Cell Carcinoma Trial in United States (LBH589)

    Completed
    Has Results
    • Renal Cell Carcinoma
    • Fort Myers, Florida
    • +9 more
    Oct 26, 2021

    APL Trial in Shanghai (Chidamide+venetoclax)

    Active, not recruiting
    • APL
    • Shanghai, Shanghai, China
      Jiong HU
    May 30, 2023

    HIV Trial in Puerto Rico, United States (Tamoxifen, Vorinostat, Antiretroviral drugs)

    Active, not recruiting
    Has Results
    • HIV Infections
    • Birmingham, Alabama
    • +13 more
    Jan 13, 2022

    Diffuse Large B Cell Lymphoma Trial (Pembrolizumab and CXD101)

    Withdrawn
    • Diffuse Large B Cell Lymphoma
    • Pembrolizumab and CXD101
    • (no location specified)
    Aug 12, 2021

    Safety and Efficacy Trial in Guangzhou, Wuhan (Sintilimab, Chidamide)

    Completed
    • Safety and Efficacy
    • Guangzhou, Guangdong, China
    • +3 more
    Apr 6, 2022

    HPV-Related Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx Trial in

    Not yet recruiting
    • HPV-Related Squamous Cell Carcinoma
    • +4 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jan 31, 2023

    Metastatic Colorectal Cancer Trial in Australia (Sodium Valproate, Panitumumab, Cetuximab)

    Recruiting
    • Metastatic Colorectal Cancer
    • Sodium Valproate
    • +2 more
    • Saint Leonards, New South Wales, Australia
    • +8 more
    Jan 22, 2023

    Cervical Cancer, Cervix Cancer, Cervix Tumor Trial in Guangzhou (Toripalimab + Chidamide)

    Recruiting
    • Cervical Cancer
    • +2 more
    • Toripalimab + Chidamide
    • Guangzhou, 广东, China
      Sun Yat-sen University Cancer Centre
    Dec 3, 2020